Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Ekso Bionics Holdings (EKSO) Enterprise Value (2016 - 2025)

Historic Enterprise Value for Ekso Bionics Holdings (EKSO) over the last 14 years, with Q3 2025 value amounting to -$2.7 million.

  • Ekso Bionics Holdings' Enterprise Value rose 6717.32% to -$2.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.7 million, marking a year-over-year increase of 6717.32%. This contributed to the annual value of -$4.5 million for FY2024, which is 4798.56% up from last year.
  • Ekso Bionics Holdings' Enterprise Value amounted to -$2.7 million in Q3 2025, which was up 6717.32% from -$5.2 million recorded in Q2 2025.
  • Ekso Bionics Holdings' Enterprise Value's 5-year high stood at -$2.7 million during Q3 2025, with a 5-year trough of -$49.5 million in Q1 2021.
  • Its 5-year average for Enterprise Value is -$20.5 million, with a median of -$13.3 million in 2023.
  • In the last 5 years, Ekso Bionics Holdings' Enterprise Value plummeted by 48171.68% in 2021 and then surged by 6717.32% in 2025.
  • Over the past 5 years, Ekso Bionics Holdings' Enterprise Value (Quarter) stood at -$40.4 million in 2021, then skyrocketed by 49.2% to -$20.5 million in 2022, then surged by 57.91% to -$8.6 million in 2023, then skyrocketed by 47.99% to -$4.5 million in 2024, then surged by 39.42% to -$2.7 million in 2025.
  • Its Enterprise Value stands at -$2.7 million for Q3 2025, versus -$5.2 million for Q2 2025 and -$8.1 million for Q1 2025.